re: Ann: FDA approves Cochlear Nucleus Hybrid... Here is an interesting comment from Motley Fool:
Foolish takeaway
Cochlear was the most-shorted individual stock on the ASX as at 14 March 2014, followed by News Corp (ASX: NWS), UGL Limited (ASX: UGL) and Monadelphous Group (ASX: MND). With Cochlear shares up 2.5% at lunchtime today, many of those shorters may well be forced to cover their positions in the days, weeks and months ahead. I certainly wouldn’t want to be standing in front of the Cochlear train at this point in time.
- Forums
- ASX - By Stock
- COH
- Ann: FDA approves Cochlear Nucleus Hybrid for sal
COH
cochlear limited
Add to My Watchlist
0.59%
!
$317.54

Ann: FDA approves Cochlear Nucleus Hybrid for sal, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$317.54 |
Change
-1.880(0.59%) |
Mkt cap ! $20.88B |
Open | High | Low | Value | Volume |
$316.74 | $318.85 | $316.74 | $3.217M | 10.13K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 20 | $317.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$317.61 | 4 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 15 | 317.730 |
3 | 13 | 317.700 |
2 | 11 | 317.690 |
1 | 3 | 317.680 |
1 | 2 | 317.660 |
Price($) | Vol. | No. |
---|---|---|
317.840 | 5 | 2 |
317.880 | 1 | 1 |
317.890 | 1 | 1 |
317.930 | 10 | 1 |
317.960 | 12 | 1 |
Last trade - 10.44am 30/07/2025 (20 minute delay) ? |
Featured News
COH (ASX) Chart |